Flagship Ventures Opportunities Fund I, L.p. - Net Worth and Insider Trading
Flagship Ventures Opportunities Fund I, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Flagship Ventures Opportunities Fund I, L.p. owns 5 companies in total, including Foghorn Therapeutics Inc (FHTX) , Evelo Biosciences Inc (EVLO) , and Kaleido Biosciences Inc (KLDO) among others .
Insider Ownership Summary of Flagship Ventures Opportunities Fund I, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FHTX | Foghorn Therapeutics Inc | 2020-10-22 | 10 percent owner |
EVLO | Evelo Biosciences Inc | 2018-05-08 | 10 percent owner |
KLDO | Kaleido Biosciences Inc | 2019-02-27 | 10 percent owner |
2020-05-18 | 10 percent owner | ||
2021-03-19 | 10 percent owner |
Flagship Ventures Opportunities Fund I, L.p. Trading Performance
Flagship Ventures Opportunities Fund I, L.p. Ownership Network
Flagship Ventures Opportunities Fund I, L.p. Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Flagship Ventures Opportunities Fund I, L.p. is the 10 percent owner of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief People Officer Carlos Costa , See Remarks Steven F. Bellon , and Chief Strategy/Bus Ops Officer Fanny Cavalie .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Flagship Ventures Opportunities Fund I, L.p. made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 311,297 shares made by Samuel Agresta , a net sale of 20,000 shares made by Steven F. Bellon , and a net sale of 11,000 shares made by Fanny Cavalie .
In summary, during the past 3 months, insiders sold 30,672 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 30,672 shares. During the past 18 months, 352,969 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 352,969 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Flagship Ventures Opportunities Fund I, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Flagship Ventures Opportunities Fund I, L.p.. You might contact Flagship Ventures Opportunities Fund I, L.p. via mailing address: One Memorial Drive, 7th Floor, Cambridge Ma 02142.